What a Certificate of Analysis (COA) Proves for a Research Peptide (and What It Doesn't)
Learn what a research peptide COA proves about identity, HPLC purity and endotoxin levels, and understand its limitations when evaluating a peptide lot.
A peptide COA proves three things about one specific lot: that the measured molecular mass matches the expected sequence (identity), what share of the UV-detected material is the target peptide (HPLC purity), and, when tested, how much bacterial endotoxin is present. It does not prove that your vial came from that lot, that the powder is all peptide by weight, that the amino acids are in the right order, or that the material is unchanged since the test date. Read a COA as a lot-level analytical record, then verify it against the vial in your hands.
What is a certificate of analysis for a research peptide?
A certificate of analysis (COA) is a report issued by a testing laboratory that records the analytical results for one specific production lot, linked to that lot by its lot or batch number.
A certificate of analysis for peptides comes either from the manufacturer's quality control lab or from an independent third-party lab testing a sample submitted by the seller. A third-party COA carries more weight because the lab has no stake in the result. It covers only the sample tested from that lot, and only the tests listed.
A specification states what a product is supposed to meet; a COA records what one lot actually measured. "High purity" on a product page is a claim. A COA with a chromatogram, a mass spectrum and a lot number is evidence.
What does a peptide COA actually prove?
A research peptide COA rests on two core tests, HPLC and mass spectrometry, sometimes with content and endotoxin testing added.
Identity: does the molecule have the right mass?
Mass spectrometry identity testing confirms that the measured molecular mass of the sample matches the mass calculated from the peptide's amino acid sequence. It is often run as LC-MS, where liquid chromatography feeds the sample into the mass spectrometer. Electrospray ionization can give one molecule one, two or more charges, so several labeled peaks may point to a single mass. A deletion or insertion sequence shifts that mass by the weight of the missing or extra residue, so a wrong main product shows up here.
Purity: how much of the detected material is the target peptide?
HPLC purity is the percentage of the total integrated peak area in a chromatogram that belongs to the main peptide peak. Peptides are usually analyzed by reversed-phase HPLC with UV detection around 214 to 220 nm, where peptide bonds absorb. The result is relative, and only as reliable as the method's ability to separate impurities from the main peak. FDA's Q2(R2) guidance describes how a lab shows an analytical method is fit for purpose, including specificity, accuracy, precision and robustness (FDA, Q2(R2)).
Endotoxin: is bacterial contamination below a stated level?
Endotoxin testing measures bacterial lipopolysaccharide contamination and usually reports the result in endotoxin units per milligram (EU/mg). The methods in USP chapter <85>, Bacterial Endotoxins Test, include gel-clot and photometric (turbidimetric or chromogenic) techniques, and FDA's endotoxin testing guidance references that chapter (FDA, Pyrogen and Endotoxins Testing: Questions and Answers). For in-vitro work it matters because lipopolysaccharide can activate many cell types in culture and confound cell-based assays. No endotoxin line means not tested, which is different from a result of zero.


lumenpeptides
